Specific binding of phorbol ester tumor promoters
Abstract
[20-H]Phorbol 12,13-dibutyrate bound to particulate preparations from chicken embryo fibroblasts in a specific, saturable, reversible fashion. Equilibrium binding occurred with a Kd of 25 nM; this value is very close to the 50% effective dose (ED50), 50 nM, previously determined for the biological response (induction of fibronectin loss) in growing chicken embryo fibroblasts. At saturation, 1.4 pmol of [20-H]phorbol 12,13-dibutyrate was bound per mg of protein (approximately 7 × 10 molecules per cell). Binding was inhibited by phorbol 12-myristate 13-acetate (Ki = 2 nM), mezerein (Ki = 180 nM), phorbol 12,13-dibenzoate (Ki = 180 nM), phorbol 12,13-diacetate (Ki = 1.7 μM), phorbol 12,13,20-triacetate (Ki = 39 μM), and phorbol 13-acetate (Ki = 120 μM). The measured Ki values are all within a factor of 3.5 of the ED50 values of these derivatives for inducing loss of fibronectin in intact cells. Binding was not inhibited by the inactive compounds phorbol (10 μg/ml) and 4α-phorbol 12,13-didecanoate (10 μg/ml) or by the inflammatory but nonpromoting phorbol-related diterpene esters resiniferatoxin (100 ng/ml) and 12-deoxyphorbol 13-isobutyrate 20-acetate (100 ng/ml). These data suggest that biological responses to the phorbol esters in chicken embryo fibroblasts are mediated by this binding activity and that the binding activity corresponds to the phorbol ester target in mouse skin involved in tumor promotion. Binding was not inhibited by the nonphorbol promoters anthralin (1 μM), phenol (1 mM), iodoacetic acid (1.7 μM), and cantharidin (75 μM), or by epidermal growth factor (100 ng/ml), dexamethasone acetate (2 μM), retinoic acid (10 μM), or prostaglandin E2 (1 μM). These agents thus appear to act at a target distinct from that of the phorbol esters.
Full text
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.0M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Scribner JD, Süss R. Tumor initiation and promotion. Int Rev Exp Pathol. 1978;18:137–198. [PubMed] [Google Scholar]
- Van Duuren BL. Tumor-promoting agents in two-stage carcinogenesis. Prog Exp Tumor Res. 1969;11:31–68. [PubMed] [Google Scholar]
- Goerttler K, Loehrke H, Schweizer J, Hesse B. Systemic two-stage carcinogenesis in the epithelium of the forestomach of mice using 7,12-dimethylbenz(a)anthracene as initiator and the phorbol ester 12-O-tetradecanoylphorbol-13-acetate as promoter. Cancer Res. 1979 Apr;39(4):1293–1297. [PubMed] [Google Scholar]
- Schweizer J, Loehrke H, Goerttler K. Transmaternal modification of the Berenblum/Mottram experiment in mice. Bull Cancer. 1978;65(3):265–270. [PubMed] [Google Scholar]
- Boutwell RK. The function and mechanism of promoters of carcinogenesis. CRC Crit Rev Toxicol. 1974 Jan;2(4):419–443. [PubMed] [Google Scholar]
- Blumberg PM, Driedger PE, Rossow PW. Effect of a phorbol ester on a transformation-sensitive surface protein of chick fibroblasts. Nature. 1976 Dec 2;264(5585):446–447. [PubMed] [Google Scholar]
- Driedger PE, Blumberg PM. The effect of phorbol diesters on chicken embryo fibroblasts. Cancer Res. 1977 Sep;37(9):3257–3265. [PubMed] [Google Scholar]
- Delclos KB, Blumberg PM. Decrease in collagen production in normal and Rous sarcoma virus-transformed chick embryo fibroblasts induced by phorbol myristate acetate. Cancer Res. 1979 May;39(5):1667–1672. [PubMed] [Google Scholar]
- Diamond L, O'Brien TG, Rovera G. Tumor promoters: effects on proliferation and differentiation of cells in culture. Life Sci. 1978 Nov 13;23(20):1979–1988. [PubMed] [Google Scholar]
- Driedger PE, Blumberg PM. Quantitative correlation between in vitro and in vivo activities of phorbol esters. Cancer Res. 1979 Mar;39(3):714–719. [PubMed] [Google Scholar]
- Jacobson K, Wenner CE, Kemp G, Papahadjopoulos D. Surface properties of phorbol esters and their interaction with lipid monolayers and bilayers. Cancer Res. 1975 Nov;35(11 Pt 1):2991–2995. [PubMed] [Google Scholar]
- Kubinyi H. Quantitative structure-activity relationships. IV. Non-linear dependence of biological activity on hydrophobic character: a new model. Arzneimittelforschung. 1976;26(11):1991–1997. [PubMed] [Google Scholar]
- Driedger PE, Blumberg PM. Non-phorbol mouse skin tumor promoters do not mimic phorbol myristate acetate in its effects on chick embryo fibroblasts. Int J Cancer. 1978 Jul 15;22(1):63–69. [PubMed] [Google Scholar]
- Kreibich G, Hecker E. Active principles of croton oil. X. Preparation of tritium labeled croton oil factor A1 and other tritium labeled phorbol derivatives. Z Krebsforsch. 1970;74(4):448–456. [PubMed] [Google Scholar]
- Hecker E, Schmidt R. Phorbolesters--the irritants and cocarcinogens of Croton Tiglium L. Fortschr Chem Org Naturst. 1974;31(0):377–467. [PubMed] [Google Scholar]
- Verma AK, Boutwell RK. Vitamin A acid (retinoic acid), a potent inhibitor of 12-O-tetradecanoyl-phorbol-13-acetate-induced ornithine decarboxylase activity in mouse epidermis. Cancer Res. 1977 Jul;37(7 Pt 1):2196–2201. [PubMed] [Google Scholar]
- Belman S, Troll W. The inhibition of croton oil-promoted mouse skin tumorigenesis by steroid hormones. Cancer Res. 1972 Mar;32(3):450–454. [PubMed] [Google Scholar]
- Wilson SR, Huffman JC. The structural relationship of phorbol and cortisol: a possible mechanism for the tumor promoting activity of phorbol. Experientia. 1976 Dec 15;32(12):1489–1490. [PubMed] [Google Scholar]
- Smythies JR, Benington F, Morin RD. On the molecular structure of receptors for co-carcinogens and some anti-cancer drugs. Psychoneuroendocrinology. 1975;1(2):123–130. [PubMed] [Google Scholar]
- Lee LS, Weinstein IB. Epidermal growth factor, like phorbol esters, induces plasminogen activator in HeLa cells. Nature. 1978 Aug 17;274(5672):696–697. [PubMed] [Google Scholar]
- Lee LS, Weinstein IB. Tumor-promoting phorbol esters inhibit binding of epidermal growth factor to cellular receptors. Science. 1978 Oct 20;202(4365):313–315. [PubMed] [Google Scholar]
- Brown KD, Dicker P, Rozengurt E. Inhibition of epidermal growth factor binding to surface receptors by tumor promotors. Biochem Biophys Res Commun. 1979 Feb 28;86(4):1037–1043. [PubMed] [Google Scholar]
- Shoyab M, De Larco JE, Todaro GJ. Biologically active phorbol esters specifically alter affinity of epidermal growth factor membrane receptors. Nature. 1979 May 31;279(5712):387–391. [PubMed] [Google Scholar]
- Hergenhahn M, Kusumoto S, Hecker E. Diterpene esters from 'Euphorbium' and their irritant and cocarcinogenic activity. Experientia. 1974 Dec 15;30(12):1438–1440. [PubMed] [Google Scholar]
- Kupchan SM, Shizuri Y, Sumner WC, Jr, Haynes HR, Leighton AP, Sickles BR. Isolation and structural elucidation of new potent antileukemic diterpenoid esters from Gnidia species. J Org Chem. 1976 Nov 26;41(24):3850–3853. [PubMed] [Google Scholar]
- Berry DL, Bracken WM, Fischer SM, Viaje A, Slaga TJ. Metabolic conversion of 12-O-tetradecanoylphorbol-13-acetate in adult and newborn mouse skin and mouse liver microsomes. Cancer Res. 1978 Aug;38(8):2301–2306. [PubMed] [Google Scholar]
- Fisher PB, Flamm M, Schachter D, Weinstein IB. Tumor promoters induce membrane changes detected by fluorescence polarization. Biochem Biophys Res Commun. 1979 Feb 28;86(4):1063–1068. [PubMed] [Google Scholar]
- Mufson RA, Laskin JD, Fisher PB, Weinstein IB. Melittin shares certain cellular effects with phorbol ester tumour promoters. Nature. 1979 Jul 5;280(5717):72–74. [PubMed] [Google Scholar]
